Drug
Umeclidinium bromide clinical trials
Also written Anoro Ellipta.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
GlaxoSmithKline (6) · Samsung Medical Center (1) · University of Virginia (1) · Queen's University (1)
Often tested with
Tested in the same studies.
Fluticasone furoate (2) · Vilanterol (2) · Vilanterol trifenatate (1) · Fluticasone (1) · GSK573719 (1)
Studies
Open first, then newest update. How each study uses umeclidinium bromide is read from its arms, and is right about nine times in ten.
Testing it · 9
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaActive, not recruitingPhase 4GlaxoSmithKlineNCT06372496Written as Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
- Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer SurgeryActive, not recruitingPhase 3Samsung Medical CenterNCT04536675Written as Vilanterol and Umeclidinium Bromide
- Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD TherapeuticsActive, not recruitingPhase 2University of VirginiaNCT03002389Written as Anoro Ellipta
- A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)CompletedPhase 3GlaxoSmithKlineNCT02184611Written as Umeclidinium bromide
- A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3GlaxoSmithKlineNCT02164513Written as umeclidinium bromide (UMEC)
- Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 WeeksCompletedPhase 3GlaxoSmithKlineNCT01772134Written as Umeclidinium bromide 62.5mcg
- A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3GlaxoSmithKlineNCT01822899Written as Umeclidinium bromide/Vilanterol
- Effect of a New Combination Bronchodilator on Exercise in GOLD Stage II Moderate COPDCompletedPhase 3Queen's UniversityNCT01491802Written as LAMA/LABA
- Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.CompletedPhase 3GlaxoSmithKlineNCT01772147Written as Umeclidinium bromide 62.5mcg
Given in every arm · 1 — umeclidinium bromide is usual care beside what is tested
As the comparator · 2 — what is tested is compared with umeclidinium bromide
- ANTES B+ Clinical TrialTerminatedPhase 4Fundacio Privada Mon Clinic BarcelonaNCT06282861Written as Incruse
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366CompletedPhase 1/2Chiesi Farmaceutici S.p.A.NCT03378648Written as umeclidinium bromide and vilanterol trifenatate
Codes
What other systems call umeclidinium bromide · ClinicalTrials.gg INT015447
- UNII (FDA) 7AN603V4JVUMECLIDINIUM BROMIDEConfirmed FDA, Wikidata
- RxNorm 1487512Confirmed FDA, Wikidata
- Wikidata Q15624035umeclidinium bromideConfirmed FDA, Wikidata
- NCI Thesaurus C152797Umeclidinium BromideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 7AN603V4JV | UMECLIDINIUM BROMIDE | Confirmed FDA, Wikidata |
| RxNorm | 1487512 | — | Confirmed FDA, Wikidata |
| Wikidata | Q15624035 | umeclidinium bromide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152797 | Umeclidinium Bromide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.